Microbiological assessment of indoor air quality at different hospital sites

Poor hospital indoor air quality (IAQ) may lead to hospital-acquired infections, sick hospital syndrome and various occupational hazards. Air-control measures are crucial for reducing dissemination of airborne biological particles in hospitals. The objective of this study was to perform a survey of bioaerosol quality in different sites in a Portuguese Hospital, namely the operating theater (OT), the emergency service (ES) and the surgical ward (SW). Aerobic mesophilic bacterial counts (BCs) and fungal load (FL) were assessed by impaction directly onto tryptic soy agar and malt extract agar supplemented with antibiotic chloramphenicol (0.05%) plates, respectively using a MAS-100 air sampler. The ES revealed the highest airborne microbial concentrations (BC range 240-736 CFU/m(3) CFU/m(3); FL range 27-933 CFU/m(3)), exceeding, at several sampling sites, conformity criteria defined in national legislation [6]. Bacterial concentrations in the SW (BC range 99-495 CFU/m(3)) and the OT (BC range 12-170 CFU/m(3)) were under recommended criteria. While fungal levels were below 1 CFU/m(3) in the OT, in the SW (range 1-32 CFU/m(3)), there existed a site with fungal indoor concentrations higher than those detected outdoors. Airborne Gram-positive cocci were the most frequent phenotype (88%) detected from the measured bacterial population in all indoor environments. Staphylococcus (51%) and Micrococcus (37%) were dominant among the bacterial genera identified in the present study. Concerning indoor fungal characterization, the prevalent genera were Penicillium (41%) and Aspergillus (24%). Regular monitoring is essential for assessing air control efficiency and for detecting irregular introduction of airborne particles via clothing of visitors and medical staff or carriage by personal and medical materials. Furthermore, microbiological survey data should be used to clearly define specific air quality guidelines for controlled environments in hospital settings.

Comet assay as a human biomonitoring tool: application in occupational exposure to antineoplastic drugs

Antineoplastic drugs are a heterogeneous group of chemicals used in the treatment of cancer, and have been proved by IARC to be mutagens, carcinogens and teratogens agents. In general, chemicals that interact directly with DNA by biding covalently or by intercalating, or indirectly by interfering with DNA synthesis, were among the first chemotherapeutics developed. Also, these drugs can induce reactive oxygen species that can lead to DNA damage and, consequently, mutations. These drugs are often used in combination to achieve synergistic effects on tumour cells resulting from their differing modes of action. However, most if not all of these chemical agents are generally nonselective and, along with tumour cells, normal cells may undergo cytotoxic/genotoxic damage. The in vivo exposure to antineoplastic drugs has been shown to induce different types of lesions in DNA, depending on the particular stage of cell cycle at the time of treatment. Besides the patients that use these drugs as a treatment, workers that handle and/or administer these drugs can be exposed to these substances; namely pharmacy, and nursing personnel in hospital context.

Uma experiência com a Global Trigger Tool no estudo dos eventos adversos num serviço de medicina

Enquadramento: A prestação de cuidados de saúde está associada aos eventos adversos (EA) que causam dano nos doentes internados em hospitais. Objetivos: Estudar os EA num serviço de Medicina. Metodologia: Realizou-se um estudo quantitativo, descritivo observacional retrospetivo, de 1 de setembro a 31 de dezembro de 2014 num serviço de medicina do Centro Hospitalar do Algarve. Para identificar os EA utilizou-se a Global Trigger Tool (GTT). Listaram-se os doentes que tiveram alta hospitalar no período de 1 de janeiro a 30 de setembro do ano 2014. Resultados: A concordância entre as revisoras, relativamente à classificação dos EA, através do índice de Kappa, demonstrou ser perfeita. Identificaram-se 278 triggers, dos quais 124 resultaram em EA, 44,6% dos EA ocorreram durante o internamento e 9,4% dos doentes apresentavam EA no momento de admissão. Constataram-se 62,63 EA por 1000 doentes dia, 137,8 EA por 100 admissões e, em 31,1% dos casos, ocorreu um EA durante o internamento. Conclusão: A metodologia GTT é uma ferramenta útil no estudo dos EA no contexto hospitalar.